Amended Final Terms
Summary by AI BETAClose X
AMENDED FINAL TERMS
Santander UK plc (the “Issuer”)
This notice relates to the following amendments in relation to the securities listed in numbered items (1) - (3) below (together, the "Securities") by the Issuer under its Structured Note and Certificate Programme.
The Issuer hereby gives notice that the Final Terms in respect of each of the Securities (the "Original Final Terms") issued under the base prospectus dated 14 March 2025 (the "Base Prospectus") have been amended and restated by a new set of Final Terms (the "Amended Final Terms") to make certain corrections to the summary annexed thereto and to amend the definition of "Preference Share Valueinitial". The Amended Final Terms replace the Original Final Terms.
- The final terms dated 28 March 2025 (as amended and restated on 12 November 2026) in respect of the issue of up to £20,000,000 Preference Share-linked Autocallable Notes due 2032, with ISIN code XS3029359554 (Series 1281);
- The final terms dated 28 March 2025 (as amended and restated on 12 November 2026) in respect of the issue of up to £20,000,000 Preference Share-linked Autocallable Notes due 2031, with ISIN code XS3029367573 (Series 1282); and
- The final terms dated 28 March 2025 (as amended and restated on 12 November 2026) in respect of the issue of up to £20,000,000 Preference Share-linked Autocallable Notes due 2031, with ISIN code XS3029370791 (Series 1283).
To view the Amended Final Terms, please click on the link below:
For further information, please contact:
The Structured Notes Desk:
structurednotesafm@santander.co.uk
DISCLAIMER - INTENDED ADDRESSEES
Please note that the information contained in the Base Prospectus and the Amended Final Terms may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus and/or the Amended Final Terms) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom the offer contained in the Base Prospectus and/or the Amended Final Terms is not addressed. Prior to relying on the information contained in the Base Prospectus and/or the Amended Final Terms, you must ascertain from the Base Prospectus and/or the Amended Final Terms whether or not you are part of the intended addressees of the information contained therein.
Your right to access this service is conditional upon complying with the above requirement.
The Amended Final Terms referenced herein do not constitute an offer of securities for sale in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America, and may not be offered or sold to U.S. persons or to persons within the United States of America, except pursuant to an exemption from the Securities Act.
END
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 1 day ago Savannah Energy
- 1 day ago Buccaneer Energy PLC
- 1 day ago Savannah Energy
- 1 day ago Carclo
- 1 day ago Schroder Japan Growth Fund